Zymeworks (ZYME) Interest Coverage Ratio (2021 - 2026)

Zymeworks (ZYME) reported Interest Coverage Ratio of 2.43 for Q1 2026, up 90.06% on a YoY basis from 1.28 in Q1 2025, and up 94.11% sequentially from 41.26 in Q4 2025.

Zymeworks (ZYME) Interest Coverage Ratio (2021 - 2026) Analysis & Trends

Zymeworks (ZYME) has 6 years of Interest Coverage Ratio data on file, last reported at 2.43 in Q1 2026.

  • For the quarter ending Q1 2026, Interest Coverage Ratio rose 90.06% year-over-year to 2.43; the trailing twelve-month figure through Mar 2026 stood at 5.88 (up 81.83% YoY), and the FY2025 full-year result was 0.34, up 38.71% from the prior year.
  • Interest Coverage Ratio climbed to 2.43 in Q1 2026, from 41.26 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 289.57 in Q4 2022 to a low of 48.68 in Q2 2024.
  • A 5-year average of 2.89 and a median of 17.31 in 2023 frame the typical range for Interest Coverage Ratio.
  • Across the five-year window, Interest Coverage Ratio jumped 4037.81% in 2022 and plunged 3216.27% in 2024, its largest moves.
  • Tracing ZYME's Interest Coverage Ratio over 5 years: stood at 289.57 in 2022, then tumbled by 105.98% to 17.31 in 2023, then sank by 34.11% to 23.22 in 2024, then sank by 77.74% to 41.26 in 2025, then surged by 94.11% to 2.43 in 2026.
  • Business Quant data shows ZYME's Interest Coverage Ratio at 2.43 in Q1 2026, 41.26 in Q4 2025, and 20.53 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Zymeworks 1.73 Bn 1.36 Bn - -2.43

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.43
Dec 31, 2025 -41.26
Sep 30, 2025 -20.53
Jun 30, 2025 -0.03
Mar 31, 2025 -24.44
Dec 31, 2024 -23.22
Sep 30, 2024 -35.15
Jun 30, 2024 -48.68
Mar 31, 2024 -28.19
Dec 31, 2023 -17.31
Sep 30, 2023 -1.07
Jun 30, 2023 -1.70
Mar 31, 2023 -0.85
Dec 31, 2022 289.57
Sep 30, 2022 -1.43
Dec 31, 2021 -7.35